Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Analyze how volatile dividend aristocrats ETF behaves in retirement and what that means for your withdrawal plan. This intro helps readers gauge risk and plan smarter.
21,930 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Insider trading activity can reveal how executives view their company’s future. This article digs into a real-world c...
Freddie Mac data show mortgage rates climbed to their highest level in almost four months, pushing the 30-year loan t...
Coinbase is guiding certain Commerce wallet users to a seed-phrase recovery path ahead of a March 31, 2026 shutdown, ...
U.S. authorities charged the co-founder of Super Micro Computer and two associates in a $2.5 billion scheme to ship s...
Solana's on-chain DApp revenue falls to $22 million, the lowest in 18 months, while SOL hovers around the $80 level a...
A major Bitcoin whale flipped from long to short, taking a 2,281 BTC position on Binance with a $169 million nominal ...
A top OpenAI cofounder reveals he hasn’t written code for months, signaling a shift toward agentic AI and raising que...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
A conflict over Iran threatens Asia's access to fertilizer and helium, risking farm yields and semiconductor supply c...
The Supreme Court looks poised to restrict late mail ballots, a move that could impact voter turnout and state electi...
Lumentum’s stock surged 1,000% over the past year as AI-driven demand for high-power lasers accelerates. A BNP Pariba...